534 related articles for article (PubMed ID: 37008622)
1. Preventing monkeypox outbreaks: Focus on diagnosis, care, treatment, and vaccination.
Ghaseminia M
J Clin Transl Sci; 2023; 7(1):e60. PubMed ID: 37008622
[TBL] [Abstract][Full Text] [Related]
2. Human monkeypox virus in the shadow of the COVID-19 pandemic.
Khamees A; Awadi S; Al-Shami K; Alkhoun HA; Al-Eitan SF; Alsheikh AM; Saeed A; Al-Zoubi RM; Zoubi MSA
J Infect Public Health; 2023 Aug; 16(8):1149-1157. PubMed ID: 37269693
[TBL] [Abstract][Full Text] [Related]
3. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
Aden D; Zaheer S; Kumar R; Ranga S
J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
De Clercq E; Jiang Y; Li G
Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
[TBL] [Abstract][Full Text] [Related]
5. Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments.
Soheili M; Nasseri S; Afraie M; Khateri S; Moradi Y; Mahdavi Mortazavi SM; Gilzad-Kohan H
J Pharm Pharm Sci; 2022; 25():297-322. PubMed ID: 36130588
[TBL] [Abstract][Full Text] [Related]
6. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115
[TBL] [Abstract][Full Text] [Related]
7. Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists.
Gupta AK; Talukder M; Rosen T; Piguet V
Am J Clin Dermatol; 2023 Jul; 24(4):541-556. PubMed ID: 37106278
[TBL] [Abstract][Full Text] [Related]
8. Mpox: Rapid Evidence Review.
Saguil A; Krebs L; Choe U
Am Fam Physician; 2023 Jul; 108(1):78-83. PubMed ID: 37440743
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis.
Shamim MA; Satapathy P; Padhi BK; Veeramachaneni SD; Akhtar N; Pradhan A; Agrawal A; Dwivedi P; Mohanty A; Pradhan KB; Kabir R; Rabaan AA; Alotaibi J; Al Ismail ZA; Alsoliabi ZA; Al Fraij A; Sah R; Rodriguez-Morales AJ
Front Pharmacol; 2023; 14():1149909. PubMed ID: 37214444
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for the Re-Emerging Human Monkeypox Virus.
Lee W; Kim YJ; Lee SJ; Ahn DG; Kim SJ
J Microbiol Biotechnol; 2023 Aug; 33(8):981-991. PubMed ID: 37519276
[TBL] [Abstract][Full Text] [Related]
11. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
[TBL] [Abstract][Full Text] [Related]
12. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis.
Karagoz A; Tombuloglu H; Alsaeed M; Tombuloglu G; AlRubaish AA; Mahmoud A; Smajlović S; Ćordić S; Rabaan AA; Alsuhaimi E
J Infect Public Health; 2023 Apr; 16(4):531-541. PubMed ID: 36801633
[TBL] [Abstract][Full Text] [Related]
13. Monkeypox: the resurgence of forgotten things.
Kim SB; Jung J; Peck KR
Epidemiol Health; 2022; 44():e2022082. PubMed ID: 36228673
[TBL] [Abstract][Full Text] [Related]
14. Emergence of monkeypox: a worldwide public health crisis.
Begum JPS; Ngangom L; Semwal P; Painuli S; Sharma R; Gupta A
Hum Cell; 2023 May; 36(3):877-893. PubMed ID: 36749539
[TBL] [Abstract][Full Text] [Related]
15. A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox.
Hung YP; Lee CC; Lee JC; Chiu CW; Hsueh PR; Ko WC
J Microbiol Immunol Infect; 2022 Oct; 55(5):795-802. PubMed ID: 36115792
[TBL] [Abstract][Full Text] [Related]
16. Antivirals With Activity Against Mpox: A Clinically Oriented Review.
Siegrist EA; Sassine J
Clin Infect Dis; 2023 Jan; 76(1):155-164. PubMed ID: 35904001
[TBL] [Abstract][Full Text] [Related]
17. Emerging pharmacological strategies for treating and preventing mpox.
Grosenbach DW; Russo AT; Blum ED; Hruby DE
Expert Rev Clin Pharmacol; 2023; 16(9):843-854. PubMed ID: 37592723
[TBL] [Abstract][Full Text] [Related]
18. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
[TBL] [Abstract][Full Text] [Related]
19. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
[TBL] [Abstract][Full Text] [Related]
20. Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks.
Islam MR; Hossain MJ; Roy A; Hasan AHMN; Rahman MA; Shahriar M; Bhuiyan MA
Health Sci Rep; 2022 Sep; 5(5):e798. PubMed ID: 36032515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
